Alexander KarpAlexander Karp earned $1B in 2024

In 2024, Dr. Phillip L. Gomez earned $138.53K in total compensation at SIGA Technologies, including $71.73K salary and $66.80K bonus. Led SIGA Technologies as CEO for 7 years.

Compensation History

Annual executive compensation data for Dr. Phillip L. Gomez, including salary, bonuses, and stock awards.

Year

2024

Total Compensation

$138.53K

Salary

$71.73K

Bonus

$66.80K

Other

$0.00

Salary

$71.73K

Board Justification

The compensation philosophy of the Company is to maintain executive base salary at a competitive level to attract and retain executives and key talent needed to accomplish the Company’s goals. In determining appropriate base salary levels and, to a lesser extent, other compensation elements, the Compensation Committee considers other factors including scope of responsibility, prior experience, past accomplishments, anticipated changes in responsibilities, and historical practices within the Company. Additionally, economic, legal and business conditions affecting the Company are also considered.

Bonus

$66.80K

Board Justification

Pro-rata cash bonus paid upon retirement in January 2024, in accordance with the terms of his amended and restated transition agreement.

Other Compensation

$0.00

Board Justification

N/A

Restricted Stock

$0.000 N/A

Board Justification

N/A

Performance Metrics

Key corporate goals, as established early each year, provide the Compensation Committee and the Board of Directors with a guide for reviewing executive officer performance in the context of the Company’s operating, business and regulatory environments. Such goals measure progress in the context of strategic, financial, commercial and regulatory activities that are believed to create enterprise value.

S

Dr. Phillip L. Gomez

Ex-CEO of SIGA Technologies

Education

Ph.D. in a relevant field

Field of Expertise

Healthcare & Life Sciences - Biotechnology

Sector of Economy

Healthcare

Born

January 1, 1973 - 52 years ago

CEO of SIGA Technologies for

7 years 3 months (Oct 2016 - Jan 2024)

Previous Experience

Various leadership roles in biotechnology and pharmaceuticals

Holdings

Track Dr. Phillip L. Gomez's stock holdings and portfolio value over time.

Insider Trading

Dr. Phillip L. Gomez's recent stock transactions, purchases, and sales filed with the SEC.

No insider trades found for this CEO.

Rivals

Compare Dr. Phillip L. Gomez with competitor CEOs and industry peers.